We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Sarah Whelan, PhD

Sarah Whelan, PhD

Science Writer

Contact Us


Sarah joined Technology Networks in May 2022 after completing a master’s degree in biochemistry from the University of Kent and a PhD in cancer biology from the University of Leicester, where her research focused on the development of colon cancers. In her role as a science writer and editor, Sarah covers scientific news and a range of other scientific content for the site.


Latest Content
A tiled mosaic floor.
News

New Technique Modifies Single Cells To Create Genetic “Mosaic” Organs

A new technique has been developed that allows different genes to be “switched off” in individual cells within an organ to create a “mosaic” of genetically modified cells, which shed light on the origins of a rare genetic disorder.
Artibeus jamaicensis, the Jamaican fruit bat.
News

How Bats’ Genomes May Help Them Avoid Cancer and Survive Viruses

A new study has analyzed the genomes of bats to investigate their ability to tolerate viral infections and avoid cancer – findings that could have implications for our knowledge of human cancers as well as virus transmission from animals.
A collection of white pills on a blue surface.
News

MDMA Helps To Reduce PTSD Symptoms in Confirmatory Clinical Trial

Findings from a new confirmatory clinical trial have shown the potential for MDMA therapy in reducing PTSD symptoms, building upon previous studies by using a more diverse patient population.
Illustration of the inside of the intestinal tract.
News

Gut Cells That Limit Inflammatory Bowel Disease Identified

A new study has characterized a specialized type of immune cell that plays a key role in protecting cells in the healthy human gut and are depleted in inflammatory bowel diseases.
White pills on a blue background.
News

Uterine Cancer Drug Gets Fast-Track Approval

A new drug – tulmimetostat – has been given fast-track approval by the US Food and Drug Administration (FDA) to treat some endometrial cancers – a type of uterine cancer.
A anatomical model of the human brain in cross-section.
News

The Body’s Own Cannabinoids May Help Us Respond to Stress

A new study has uncovered how circuits within the brain work to produce the body’s own cannabinoids in order to cope with stressful experiences and opens up new possibilities for the development of drugs for stress-related psychiatric disorders.
Computer-generated image of cancer cells.
News

Link Between Inflammation and Leukemia Development Identified

Relatively little was known about the mechanisms underlying how these mutated HSCs expand to cause cancer. In the current study researchers from the University of Oxford explored how chronic inflammation has a previously unknown effect on TP53-mutant HSCs in cancer development.
A laboratory flask made from foliage.
Industry Insight

A Spotlight on Sustainability in Pharma and Biopharma

How can the industry as a whole address sustainability issues? What are the key needs and goals of pharma and biopharma laboratories when it comes to sustainability?
An illustration of a DNA double helix.
News

Genetics May Affect Responses to Popular Diabetes and Weight Loss Drugs

Patient responses to glucagon-like peptide 1 (GLP-1R) agonist drugs – used to treat type 2 diabetes and obesity – may depend on variations in GLP-1R genes, according to a new study.
Illustration of the human body highlighting the kidneys.
News

Humanized Kidneys Grown in Pig Embryos in World-First

Researchers have grown early humanized kidneys in pig–human embryos at 28 days of gestation – the first time a solid humanized organ has been grown in another species.
Advertisement